Literature DB >> 2784005

Identity of human B-cell line cytotoxic lymphokine with tumor necrosis factor type beta.

H I Yamanaka1, A Karpas.   

Abstract

A humoral cytotoxic protein that is spontaneously produced by a cloned human lymphoblastoid cell line (K160b) was partially purified by a simple three-step column chromatography procedure and NaDodSO4/polyacrylamide gel electrophoresis. Proteins were electrically blotted onto a polyvinylidene difluoride membrane, and a band of the cytotoxic protein was excised after staining with Coomassie brilliant blue. Direct analysis of the amino acid sequence of this protein showed the primary structure of its N-terminal region was identical to that of natural tumor necrosis factor type beta (TNF-beta). The 24-kDa molecular mass of the cytotoxic protein, determined by NaDodSO4/PAGE, and its elution profiles from various types of columns correlated with those of natural TNF-beta. Specific activity of the cytotoxicity, standardized with recombinant TNF-beta, was comparable to that of the purified factor. However, polyclonal antiserum to recombinant TNF-beta failed to react with the purified factor. Since recombinant TNF-beta, when used in patients, causes unacceptable side effects, which may be due to absence of glycosylation, the cell line K160b could be a useful source of natural TNF-beta for clinical trials.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784005      PMCID: PMC286686          DOI: 10.1073/pnas.86.4.1343

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Regulation of neutrophil migration and superoxide production by recombinant tumor necrosis factors-alpha and -beta: comparison to recombinant interferon-gamma and interleukin-1 alpha.

Authors:  I S Figari; N A Mori; M A Palladino
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

2.  Primary structure of human lymphotoxin derived from 1788 lymphoblastoid cell line.

Authors:  B B Aggarwal; W J Henzel; B Moffat; W J Kohr; R N Harkins
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

3.  Identification of human lymphocyte-derived lymphotoxins with binding and cell-lytic activity on NK-sensitive cell lines in vitro.

Authors:  M L Weitzen; R S Yamamoto; G A Granger
Journal:  Cell Immunol       Date:  1983-04-01       Impact factor: 4.868

4.  HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin.

Authors:  R Pujol-Borrell; I Todd; M Doshi; G F Bottazzo; R Sutton; D Gray; G R Adolf; M Feldmann
Journal:  Nature       Date:  1987 Mar 19-25       Impact factor: 49.962

5.  Purified native and recombinant human alpha lymphotoxin [tumor necrosis factor (TNF)-beta] induces inflammatory reactions in normal skin.

Authors:  B J Averbook; R S Yamamoto; T R Ulich; E W Jeffes; I Masunaka; G A Granger
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

6.  Recombinant human alpha lymphotoxin (tumor necrosis factor-beta) induces peripheral neutrophilia and lymphopenia in the rat.

Authors:  T R Ulich; J del Castillo; M Keys; G A Granger
Journal:  Am J Pathol       Date:  1987-07       Impact factor: 4.307

7.  B-cell line-derived interleukin 1 is cytotoxic for melanoma cells and promotes the proliferation of an astrocytoma cell line.

Authors:  J H Bertoglio; L Rimsky; E S Kleinerman; L B Lachman
Journal:  Lymphokine Res       Date:  1987

8.  Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption.

Authors:  P Stashenko; F E Dewhirst; W J Peros; R L Kent; J M Ago
Journal:  J Immunol       Date:  1987-03-01       Impact factor: 5.422

9.  Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity.

Authors:  P W Gray; B B Aggarwal; C V Benton; T S Bringman; W J Henzel; J A Jarrett; D W Leung; B Moffat; P Ng; L P Svedersky
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

10.  Leukoregulin, a direct-acting anticancer immunological hormone that is distinct from lymphotoxin and interferon.

Authors:  J H Ransom; C H Evans; R P McCabe; N Pomato; J A Heinbaugh; M Chin; M G Hanna
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

View more
  1 in total

1.  Relationship between a novel human cytotoxin (factor 2) produced by a B cell line (Karpas 160) and phorbol-myristate-acetate-associated cytotoxicity.

Authors:  J Ni; A Karpas
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.